Literature DB >> 29783081

Recent technological advancements in tuberculosis diagnostics - A review.

Shagun Gupta1, Vipan Kakkar2.   

Abstract

Early diagnosis and on-time effective treatment are indispensable for Tuberculosis (TB) control - a life threatening infectious communicable disease. The conventional techniques for diagnosing TB normally take two to three weeks. This delay in diagnosis and further increase in detection complexity due to the emerging risks of XDR-TB (Extensively drug Resistant-TB) and MDR-TB (Multidrug Resistant-TB) are evoking interest of researchers in the field of developing rapid TB detection techniques such as biosensing and other point-of-care (POC) techniques. Biosensing technologies along with the collaboration with nanotechnology have enormous potential to boost the MTB detection and for overall management in clinical diagnosis. A diverse range of portable, sensitive and rapid biosensors based on different signal transducer principles and with different biomarkers detection capabilities have been developed for TB detection in the early stages. Further, a lot of progress has been achieved over the years in developing various point-of-care diagnostic tools including non-molecular methods and molecular techniques. The objective of this study is to present a succinct review of the available TB detection techniques that are either in use or under development. The focus of this review is on the current developments occurred in nano-biosensing technologies. A synopsis of ameliorations in different non-molecular diagnostic tools and progress in the field of molecular techniques along with the role of emerging Lab-on-Chip technology for diagnosing and mitigating the TB consequences have also been presented.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  LTBI (Latent TB infections); LoC (Lab-on-Chip); MDR-TB (Multidrug Resistant-TB); MTB (Mycobacterium tuberculosis); MTBC (M. tuberculosis complex); NAAT; TB; XDR-TB (Extensively drug resistant - TB)

Mesh:

Substances:

Year:  2018        PMID: 29783081     DOI: 10.1016/j.bios.2018.05.017

Source DB:  PubMed          Journal:  Biosens Bioelectron        ISSN: 0956-5663            Impact factor:   10.618


  6 in total

1.  Lateral Flow Genochromatographic Strip for Naked-Eye Detection of Mycobacterium Tuberculosis PCR Products with Gold Nanoparticles as a Reporter.

Authors:  Nazari-Vanani R; Tondro G H; Dehdari Vais R; Haghkhah M; Heli H; Sattarahmady N
Journal:  J Biomed Phys Eng       Date:  2020-06-01

2.  Plasma indoleamine 2,3-dioxygenase activity as a potential biomarker for early diagnosis of multidrug-resistant tuberculosis in tuberculosis patients.

Authors:  Wen Shi; Juan Wu; Qi Tan; Chun-Mei Hu; Xia Zhang; Hong-Qiu Pan; Zhen Yang; Meng-Yu He; Min Yu; Bo Zhang; Wei-Ping Xie; Hong Wang
Journal:  Infect Drug Resist       Date:  2019-05-14       Impact factor: 4.003

Review 3.  Advances in airborne microorganisms detection using biosensors: A critical review.

Authors:  Jinbiao Ma; Manman Du; Can Wang; Xinwu Xie; Hao Wang; Qian Zhang
Journal:  Front Environ Sci Eng       Date:  2021-04-05

4.  MPT64 assays for the rapid detection of Mycobacterium tuberculosis.

Authors:  Xun-Jie Cao; Ya-Ping Li; Jia-Ying Wang; Jie Zhou; Xu-Guang Guo
Journal:  BMC Infect Dis       Date:  2021-04-10       Impact factor: 3.090

5.  Detection of Mycobacterium tuberculosis in clinical sputum by a unique gene in MTB strains called Conserved protein TB18.5 (TB18.5).

Authors:  Juanxiu Luo; Xiaofei Li; Yuzhu Song; Hongwei Liu; Kexi Zheng; Xueshan Xia; A-Mei Zhang
Journal:  J Clin Lab Anal       Date:  2021-09-30       Impact factor: 2.352

Review 6.  Recent advances in the detection of interferon-gamma as a TB biomarker.

Authors:  Kaylin Cleo Januarie; Onyinyechi V Uhuo; Emmanuel Iwuoha; Usisipho Feleni
Journal:  Anal Bioanal Chem       Date:  2021-10-19       Impact factor: 4.142

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.